Quantcast
Channel: Valerie Bauman RSS Feed
Viewing all articles
Browse latest Browse all 484

Dendreon CEO to step down after challenges with prostate cancer drug

$
0
0
Seattle-based Dendreon Corporation publicly announced Monday the resignation of its president and CEO John Johnson. Company officials said in a release that Johnson was leaving for personal reasons, and will remain the CEO until Aug.15. Johnson also resigned from his role as chairman of the board, effective June 3. Douglas Watson, Dendreon’s lead independent director, has taken over as board chair. Johnson became CEO in February 2012, replacing former CEO Mitch Gold, who had held the title since…

Viewing all articles
Browse latest Browse all 484

Trending Articles